SPY enters the final stretch of July with a clean split between two positioning signals: short sellers have largely finished their post-ceasefire exit, and options traders are now carrying the defensive flag on their own.
The short cover that defined the week of July 21–25 is now complete and embedded in the data. Shares short have barely moved since the big unwind — 96.45 million on Tuesday July 28, virtually unchanged from the 96.4 million reading on July 27 and the 96.6 million that closed the cover on July 24. As a percentage of the free float, SI holds at 9.4%, down roughly a full percentage point from the 10.5–10.6% plateau that held for ten sessions before the Iran ceasefire announcement. The month-on-month decline is now 14.6%. Shorts are not rebuilding. The Iran thesis that drove the prior accumulation is gone, and what remains is a baseline position rather than a fresh directional bet.
The borrow market confirms that shorts are not under pressure to do anything. Availability has exploded to 2,802% — roughly 28 shares sitting available for every one currently lent out, and a dramatic swing from the 1,047% reading as recently as July 21. That loosening tracks exactly with the cover: as shares were returned to the lending pool, available supply ballooned. Cost to borrow ticked up 32% on the week to 0.28%, but that remains negligibly cheap for a benchmark ETF of this size and tells borrowers very little about urgency. The short score has eased to 44.1, its lowest reading of the past ten sessions, reinforcing that the short-side pressure has genuinely dissipated.
Options traders, by contrast, have swung sharply defensive — and the divergence from short positioning is the most interesting feature of the current setup. The put/call ratio jumped to 1.99 on July 28, up from 1.67 just the session before. That's a z-score of 2.14 relative to the 20-day mean of 1.75, meaning Monday's reading was unusually elevated even by SPY's structurally put-heavy standards. The 52-week high sits at 2.40, so this is a genuine spike but not the outer extreme. What is striking is the speed: the PCR had spent the prior two weeks grinding lower from the defensive levels seen in mid-June, and then reversed the entire move in a single session. Whether that reflects macro hedging, fresh geopolitical anxiety, or simply mechanical rebalancing at month-end is not legible from the data alone — but the demand for downside protection is real and the timing is abrupt.
The institutional picture adds some texture. JPMorgan added 1.2 million shares in Q1 while Morgan Stanley moved more aggressively, adding 11.1 million to reach a 4% stake. Jane Street — a market maker rather than a directional investor — added 10.3 million shares, likely reflecting ordinary ETF creation/redemption mechanics. These Q1 13F flows don't change the immediate picture, but the scale of Morgan Stanley's addition is worth noting as context for the broader institutional appetite for the ETF at current levels.
What to watch next: whether the PCR spike on July 28 proves transient — reverting toward the 1.65–1.75 range that prevailed through most of July — or marks the beginning of a new defensive accumulation cycle that could eventually pull short interest off its current floor.
See the live data behind this article on ORTEX.
Open SPY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
